Silver Cross Hospital

Applied UV, Inc. and Silver Cross Hospital Illuminate the Future of Healthcare With Innovative Far-UVC 222nm Technology

Retrieved on: 
Wednesday, December 13, 2023

This significant initiative positions Silver Cross Hospital as a national leader in adopting advanced technology to ensure patient and staff safety.

Key Points: 
  • This significant initiative positions Silver Cross Hospital as a national leader in adopting advanced technology to ensure patient and staff safety.
  • The Far-UVC 222nm light technology, a product of the strategic partnership with Acuity Brands, is acclaimed for its ability to inactivate harmful pathogens, including viruses and bacteria, while being safe for human exposure.
  • The installation of Puro Protect 222nm fixtures at Silver Cross Hospital greatly enhances manual disinfection processes, effectively reducing microbial contamination on high-touch surfaces, sinks, and pass-through windows.
  • Jim Tyrell, Manager of the Sterile Processing at Silver Cross Hospital, emphasized the impact of this partnership, stating, "Integrating the Far-UVC technology, especially the PURO Protect system co-developed with Acuity Brands, into our SPD is a groundbreaking achievement for Silver Cross Hospital.

Old National’s Jim Roolf Named Illinois Bankers Association 2023 Banker of the Year

Retrieved on: 
Thursday, August 31, 2023

CHICAGO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) – Jim Roolf, senior vice president and corporate relations officer of Old National Bank, received the Illinois Bankers Association’s (IBA) top honor when he was named 2023 Banker of the Year.

Key Points: 
  • CHICAGO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) – Jim Roolf, senior vice president and corporate relations officer of Old National Bank, received the Illinois Bankers Association’s (IBA) top honor when he was named 2023 Banker of the Year.
  • The Banker of the Year award recognizes an individual whose dedication to excellence has profoundly enhanced the banking industry.
  • “His engagement and effective leadership are consistent with our core values and further the long-term success of our company.”
    “Jim Roolf exemplifies everything we hold dear about banking in Illinois.
  • His drive and commitment to the industry and his community have created a lasting legacy,” said Randy Hultgren, president and CEO of the Illinois Bankers Association.

Silver Cross Hospital Expands Use of Kyruus' Award-Winning Online Scheduling Solution Across Specialties and Services

Retrieved on: 
Tuesday, June 20, 2023

BOSTON, June 20, 2023 /PRNewswire/ -- Kyruus, the leader in healthcare provider data management, price transparency, and patient access and engagement, today announced that Silver Cross Hospital, an Illinois based not-for-profit community hospital, is expanding its use of Kyruus' award winning ProviderMatch platform. A customer since early 2021, Silver Cross first partnered with Kyruus to help launch consumer self-service scheduling for a variety of preventive and diagnostic services including annual screening mammograms, CT scans, lab appointments, and more.

Key Points: 
  • A customer since early 2021, Silver Cross first partnered with Kyruus to help launch consumer self-service scheduling for a variety of preventive and diagnostic services including annual screening mammograms, CT scans, lab appointments, and more.
  • Supported by Kyruus' foundational provider data and inventory management capabilities, Silver Cross launched their initial online scheduling program focused on driving patients to the right diagnostic and preventive services through self-service.
  • They saw immediate impact on their organization—in the first six months, consumers self-scheduled over 500 appointments per month for key services such as mammograms, ultrasounds, and lab services.
  • Encouraged by the demand for digital self-service from consumers, Silver Cross expanded its online scheduling program to include providers across primary care, gastroenterology, and cardiology.

Industry Veteran Jeff Janicek Joins Gilbane Chicago as Senior Project Executive

Retrieved on: 
Tuesday, January 24, 2023

CHICAGO, Jan. 24, 2023 /PRNewswire-PRWeb/ -- Gilbane Building Company announced today that Jeff Janicek joined the team as a senior project executive and healthcare market leader for the Chicago business unit. Janicek has 37 years of experience in the Midwest construction industry. He will leverage his unique and relevant expertise to drive project consistency and elevate Gilbane's focus on the healthcare, life sciences, and higher education markets.

Key Points: 
  • CHICAGO, Jan. 24, 2023 /PRNewswire-PRWeb/ -- Gilbane Building Company announced today that Jeff Janicek joined the team as a senior project executive and healthcare market leader for the Chicago business unit.
  • He will leverage his unique and relevant expertise to drive project consistency and elevate Gilbane's focus on the healthcare, life sciences, and higher education markets.
  • In his role, Janicek will combine his construction expertise with best practices and lessons learned from various experiences to expand Gilbane's strong project portfolio.
  • "We are thrilled to have Jeff Janicek join our leadership team in Chicago.

FREENOME LAUNCHES ITS FIRST STUDY FOR THE DETECTION OF MULTIPLE CANCERS THAT PAIRS MULTIOMICS WITH REAL-WORLD DATA

Retrieved on: 
Tuesday, September 6, 2022

Freenome uses a multiomics platform, combining tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw.

Key Points: 
  • Freenome uses a multiomics platform, combining tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw.
  • The Sanderson Study will enroll approximately 8,000 patients through Freenome's clinical study partner network and numerous regional health systems across the United States.
  • The study will focus on those cancers with significant unmet needs such as pancreatic and lung cancer.
  • Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw.